Form 4: Stryker COO Spencer Stiles Reports Stock Transactions
Insider Transaction Report
Stryker's President and COO, Spencer S. Stiles, reported the acquisition of 430 shares from dividend equivalents and the disposition of 6,690 shares for tax purposes.
Summary
- Spencer S. Stiles, President and COO of Stryker Corp (SYK), reported transactions on March 21, 2026, under a Rule 10b5-1 plan.
- Acquired 430 shares of Common Stock through dividend equivalents related to previously earned Performance Stock Units. These shares vested on March 21, 2026, and were settled for an equal number of common shares.
- Disposed of 6,690 shares of Common Stock at a price of $335.67 per share, likely to cover tax liabilities associated with the vesting of equity awards.
- Following these transactions, Stiles directly owns 77,634 shares of Stryker Common Stock and indirectly owns 1,670 shares through a 401K plan.
- Previously, on March 11, 2026, Stiles reported the acquisition of 14,912 Performance Stock Units, which also vested on March 21, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, reflecting routine executive compensation and tax-related transactions rather than a significant positive or negative development for the company or its stock.
Positives
- Acquisition of 430 shares of Common Stock through dividend equivalents, increasing direct ownership.
- The vesting of 14,912 Performance Stock Units and 430 dividend equivalent shares indicates the satisfaction of performance criteria and continued executive compensation.
Negatives
- Disposition of 6,690 shares of Common Stock, reducing direct ownership, although this is a common practice for tax withholding.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that routine insider transactions like this Form 4, involving vesting and tax-related sales, are common across the medical technology and broader corporate sectors. They typically reflect standard executive compensation practices rather than a change in strategic outlook or significant market sentiment.
Comparison to Industry Standards
- StockSavvy.ai observes that the practice of executives selling a portion of vested equity awards to cover tax obligations is a standard industry practice, consistent with compensation structures seen at peer companies in the medical device sector such as Medtronic (MDT) or Johnson & Johnson (JNJ).
- The acquisition of shares through dividend equivalents is also a common feature of performance-based equity awards across various industries.
Stakeholder Impact
- Shareholders: Minimal direct impact as these are routine executive compensation transactions, not indicative of a change in company fundamentals.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 03/11/2026 | Reporting Person filed a Form 4 reporting the acquisition of 14,912 shares of Stryker Common Stock earned upon satisfaction of performance criteria. |
| 03/21/2026 | Date of transactions, including acquisition of dividend equivalents, disposition for tax, and vesting of Performance Stock Units and dividend equivalents. |
| 03/24/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Stryker, SYK, Spencer Stiles, insider trading, Form 4, stock transaction, common stock, dividend equivalents, performance stock units, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.